Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ostroff

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Antimicrobial Agents and Chemotherapy|December 15, 2020
Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of HumansHanchen Li, Ambily Abraham, David Gazzola, et al.
International Journal for Parasitology. Drugs and Drug Resistance|May 18, 2018
Bacillus thuringiensis Cry5B protein as a new pan-hookworm cureYan Hu, Thanh-Thanh Nguyen, Alice C Y Lee, et al.
International Journal of Molecular Sciences|December 30, 2025
Catalytically Active Recombinant Cysteine Proteases of <i>Haemonchus contortus:</i> Their Ability to Degrade Host Blood Proteins and Modulate CoagulationAthira C Karunakaran, Mariam Bakshi, Arunraj M Rajendrakumar, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 26, 2020
A new paraprobiotic-based treatment for control of Haemonchus contortus in sheepJohn Sanders, Yue Xie, David Gazzola, et al.
Mbio|November 30, 2017
Vaccination with Recombinant <i>Cryptococcus</i> Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal SpeciesCharles A Specht, Chrono K Lee, Haibin Huang, et al.
The Biochemical Journal|March 23, 2011
Glucan particles for selective delivery of siRNA to phagocytic cells in miceGregory J Tesz, Myriam Aouadi, Matthieu Prot, et al.
Microbiology Spectrum|August 10, 2022
Efficient and Scalable Process to Produce Novel and Highly Bioactive Purified Cytosolic Crystals from Bacillus thuringiensisJeffrey Chicca, Nicholas R Cazeault, Florentina Rus, et al.
Brain : a Journal of Neurology|January 25, 2014
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulationUlrike Träger, Ralph Andre, Nayana Lahiri, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Antimicrobial Agents and Chemotherapy|December 15, 2020
Recombinant Paraprobiotics as a New Paradigm for Treating Gastrointestinal Nematode Parasites of HumansHanchen Li, Ambily Abraham, David Gazzola, et al.
International Journal for Parasitology. Drugs and Drug Resistance|May 18, 2018
Bacillus thuringiensis Cry5B protein as a new pan-hookworm cureYan Hu, Thanh-Thanh Nguyen, Alice C Y Lee, et al.
International Journal of Molecular Sciences|December 30, 2025
Catalytically Active Recombinant Cysteine Proteases of <i>Haemonchus contortus:</i> Their Ability to Degrade Host Blood Proteins and Modulate CoagulationAthira C Karunakaran, Mariam Bakshi, Arunraj M Rajendrakumar, et al.
International Journal for Parasitology. Drugs and Drug Resistance|November 26, 2020
A new paraprobiotic-based treatment for control of Haemonchus contortus in sheepJohn Sanders, Yue Xie, David Gazzola, et al.
Mbio|November 30, 2017
Vaccination with Recombinant <i>Cryptococcus</i> Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal SpeciesCharles A Specht, Chrono K Lee, Haibin Huang, et al.
The Biochemical Journal|March 23, 2011
Glucan particles for selective delivery of siRNA to phagocytic cells in miceGregory J Tesz, Myriam Aouadi, Matthieu Prot, et al.
Microbiology Spectrum|August 10, 2022
Efficient and Scalable Process to Produce Novel and Highly Bioactive Purified Cytosolic Crystals from Bacillus thuringiensisJeffrey Chicca, Nicholas R Cazeault, Florentina Rus, et al.
Brain : a Journal of Neurology|January 25, 2014
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulationUlrike Träger, Ralph Andre, Nayana Lahiri, et al.
Pageof 7